On the contrary, it is reported that NR4A1 is overexpressed in bladder, breast, pancreatic, colon, and lung cancer [24,29,56,57,58] and is associated with poor survival in breast and lung cancer patients [41,59]. This evidence concerns the gene NR4A1 and lung carcinoma.